Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Donohue

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Cardiovascular Nursing|August 1, 1988
Multisystem crisis: a case studyM C Donohue, J Vitello-Cicciu
The Journal of Nutrition, Health & Aging|April 14, 2012
Mixed model of repeated measures versus slope models in Alzheimer's disease clinical trialsM C Donohue, P S Aisen
Statistics in Medicine|June 24, 2025
Comments on "Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods"M C Donohue, P S Insel, O Langford
Biometrika|July 24, 2012
Conditional Akaike information under generalized linear and proportional hazards mixed modelsM C Donohue, R Overholser, R Xu, et al.
The Journal of Nutrition, Health & Aging|October 2, 2018
Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?N Coley, R Raman, M C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 StudyK V Papp, P Maruff, D M Rentz, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4D Molina-Henry, O Langford, M C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical TrialsO Langford, R Raman, R A Sperling, et al.
Contemporary Clinical Trials|May 11, 2011
The relative efficiency of time-to-threshold and rate of change in longitudinal dataM C Donohue, A C Gamst, R G Thomas, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Cardiovascular Nursing|August 1, 1988
Multisystem crisis: a case studyM C Donohue, J Vitello-Cicciu
The Journal of Nutrition, Health & Aging|April 14, 2012
Mixed model of repeated measures versus slope models in Alzheimer's disease clinical trialsM C Donohue, P S Aisen
Statistics in Medicine|June 24, 2025
Comments on "Novel Non-Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods"M C Donohue, P S Insel, O Langford
Biometrika|July 24, 2012
Conditional Akaike information under generalized linear and proportional hazards mixed modelsM C Donohue, R Overholser, R Xu, et al.
The Journal of Nutrition, Health & Aging|October 2, 2018
Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?N Coley, R Raman, M C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 StudyD M Rentz, P B Rosenberg, R A Sperling, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 StudyK V Papp, P Maruff, D M Rentz, et al.
The Journal of Prevention of Alzheimer'S Disease|July 24, 2024
Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4D Molina-Henry, O Langford, M C Donohue, et al.
The Journal of Prevention of Alzheimer'S Disease|September 13, 2020
Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical TrialsO Langford, R Raman, R A Sperling, et al.
Contemporary Clinical Trials|May 11, 2011
The relative efficiency of time-to-threshold and rate of change in longitudinal dataM C Donohue, A C Gamst, R G Thomas, et al.
Pageof 3